<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>2664-3243</journal-id>
<journal-title><![CDATA[Vive Revista de Salud]]></journal-title>
<abbrev-journal-title><![CDATA[Vive Rev. Salud]]></abbrev-journal-title>
<issn>2664-3243</issn>
<publisher>
<publisher-name><![CDATA[CET-BOLIVIA]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S2664-32432022000200481</article-id>
<article-id pub-id-type="doi">10.33996/revistavive.v5i14.162</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Dislipidemias en pacientes diabéticos internados en el Hospital Vicente Corral Moscoso]]></article-title>
<article-title xml:lang="en"><![CDATA[Dyslipidemias in diabetic patients hospitalized at the Vicente Corral Moscoso Hospital]]></article-title>
<article-title xml:lang="pt"><![CDATA[Dislipidemias em doentes diabéticos hospitalizados no Hospital Vicente Corral Moscoco]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Cobos]]></surname>
<given-names><![CDATA[Ana Belén Orellana]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Collazo]]></surname>
<given-names><![CDATA[Carlos Alberto Román]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Cobos]]></surname>
<given-names><![CDATA[Danilo Fernando Orellana]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Universidad Católica de Cuenca  ]]></institution>
<addr-line><![CDATA[Cuenca ]]></addr-line>
<country>Ecuador</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>08</month>
<year>2022</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>08</month>
<year>2022</year>
</pub-date>
<volume>5</volume>
<numero>14</numero>
<fpage>481</fpage>
<lpage>494</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.org.bo/scielo.php?script=sci_arttext&amp;pid=S2664-32432022000200481&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.bo/scielo.php?script=sci_abstract&amp;pid=S2664-32432022000200481&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.bo/scielo.php?script=sci_pdf&amp;pid=S2664-32432022000200481&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[RESUMEN La Diabetes Mellitus tipo 2 como una enfermedad endocrino metabólica puede generar alteraciones importantes en el perfil lipídico del paciente, por tanto, un importante riesgo cardiovascular. Objetivo. Caracterizar las dislipidemias en pacientes diabéticos internados en el área de clínica del Hospital Vicente Corral Moscoso de Cuenca durante el año 2019. Materiales y Métodos. Investigación cuantitativa, no experimental, transversal, observacional de tipo descriptivo y documental, de 137 pacientes diabéticos. Se analizaron variables sociodemográficas, cuantificación del lipidograma, HbA1c, IMC, adherencia al tratamiento, años de diagnóstico, tipo de tratamiento, presencia de hipotiroidismo e hipertensión. Se realizó análisis de frecuencias, medidas de tendencia central, chi cuadrado, Odds ratio y Riesgo Relativo. Para los análisis se consideró p&lt;0,05. Resultados. La media de edad fue de 65,73±15,11 años, correspondiendo al grupo etario adulto mayor; con predominio de mujeres. Alrededor del 46% presentaban IMC normal y 52,2% obesidad y sobrepeso. El 51% tenía tiempo de diagnóstico menor o igual a 10 años. El 76,7% de pacientes presentaron dislipidemia, 43,6% hipercolesterolemia, 57,9% hipertrigliceridemia; 60,9% disminución de HDL; 50,4% valores elevados de LDL; y 74,4% VLDL elevado. El 83,3% de pacientes presentaron hemoglobina glicosilada elevada, con falta de adherencia al tratamiento del 66,2%. Conclusión. Los pacientes diabéticos presentan dentro del transtorno metabólico dislipidemias, con hipertrigliceridemia mantenida, hipercolesterolemia, disminución de HDL y aumento de LDL. La asociación de dislipidemias con la hemoglobina glicosilada la convierte en un valor predictor de presentar enfermedades cardiovasculares.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[ABSTRACT Diabetes Mellitus type 2 as an endocrine metabolic disease can generate important alterations in the lipid profile of the patient, therefore, an important cardiovascular risk. Objective. To characterize dyslipidemias in diabetic patients hospitalized in the clinical area of the Vicente Corral Moscoso Hospital of Cuenca during 2019. Materials and Methods. Quantitative, non-experimental, cross-sectional, observational, descriptive and documentary research of 137 diabetic patients. Sociodemographic variables, lipidogram quantification, HbA1c, BMI, adherence to treatment, years of diagnosis, type of treatment, presence of hypothyroidism and hypertension were analyzed. Frequency analysis, measures of central tendency, chi-square, Odds ratio and Relative Risk were performed. For the analyses, p&lt;0.05 was considered. Results. The mean age was 65.73±15.11 years, corresponding to the older adult age group; with a predominance of women. About 46% had normal BMI and 52.2% had obesity and overweight. Fifty-one percent of the patients had been diagnosed less than or equal to 10 years. 76.7% of patients presented dyslipidemia, 43.6% hypercholesterolemia, 57.9% hypertriglyceridemia; 60.9% decreased HDL; 50.4% elevated LDL values; and 74.4% elevated VLDL. A total of 83.3% of patients had elevated glycosylated hemoglobin, with a lack of adherence to treatment of 66.2%. Conclusion. Diabetic patients present dyslipidemias within the metabolic disorder, with maintained hypertriglyceridemia, hypercholesterolemia, decreased HDL and increased LDL. The association of dyslipidemia with glycosylated hemoglobin makes it a predictor of cardiovascular disease.]]></p></abstract>
<abstract abstract-type="short" xml:lang="pt"><p><![CDATA[RESUMO Diabetes Mellitus tipo 2 como doença endócrino-metabólica pode gerar alterações importantes no perfil lipídico do paciente, portanto, um risco cardiovascular importante. Objetivo. Caracterizar dislipidemias em pacientes diabéticos internados na área clínica do Hospital Vicente Corral Moscoso em Cuenca durante 2019. Materiais e métodos. Pesquisa quantitativa, não-experimental, transversal, observacional, descritiva e documental de 137 pacientes diabéticos. Foram analisadas variáveis sociodemográficas, quantificação lipidográfica, HbA1c, IMC, aderência ao tratamento, anos de diagnóstico, tipo de tratamento, presença de hipotireoidismo e hipertensão. Foram realizadas análises de freqüência, medidas de tendência central, qui-quadrado, razão de chances e risco relativo. P&lt;0,05 foi considerado para as análises. Resultados. A idade média foi de 65,73±15,11 anos, correspondendo à faixa etária dos adultos mais velhos; com predomínio das mulheres. Cerca de 46% tinham um IMC normal e 52,2% eram obesos ou acima do peso. Cinqüenta e um por cento haviam sido diagnosticados menos ou igual a 10 anos antes do diagnóstico. 76,7% dos pacientes apresentavam dislipidemia, 43,6% hipercolesterolemia, 57,9% hipertrigliceridemia; 60,9% diminuíram o HDL; 50,4% elevaram os valores de LDL; e 74,4% elevaram o VLDL. 83,3% dos pacientes tinham hemoglobina glicosilada elevada, com 66,2% de não aderência ao tratamento. Conclusão. Os pacientes diabéticos apresentam dislipidemias dentro do distúrbio metabólico, com hipertrigliceridemia sustentada, hipercolesterolemia, diminuição do HDL e aumento do LDL. A associação de dislipidemia com a hemoglobina glicosilada faz dela um preditor de doenças cardiovasculares.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[Dislipidemias]]></kwd>
<kwd lng="es"><![CDATA[Diabetes Mellitus]]></kwd>
<kwd lng="es"><![CDATA[Índice de masa corporal]]></kwd>
<kwd lng="es"><![CDATA[Hemoglobina A Glucada]]></kwd>
<kwd lng="en"><![CDATA[Dyslipidemias]]></kwd>
<kwd lng="en"><![CDATA[Diabetes mellitus]]></kwd>
<kwd lng="en"><![CDATA[Body Mass Index]]></kwd>
<kwd lng="en"><![CDATA[Glycated Hemoglobin]]></kwd>
<kwd lng="pt"><![CDATA[Dislipidemia]]></kwd>
<kwd lng="pt"><![CDATA[Diabetes mellitus]]></kwd>
<kwd lng="pt"><![CDATA[Índice de Massa Corporal]]></kwd>
<kwd lng="pt"><![CDATA[Hemoglobina Glicada]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<nlm-citation citation-type="">
<collab>International Diabetes Federation</collab>
<source><![CDATA[Atlas de la Diabetes de la FID]]></source>
<year>2019</year>
</nlm-citation>
</ref>
<ref id="B2">
<nlm-citation citation-type="journal">
<collab>OECD</collab>
<article-title xml:lang=""><![CDATA[The World Bank]]></article-title>
<source><![CDATA[Panorama de la Salud: Latinoamérica y el Caribe]]></source>
<year>2020</year>
</nlm-citation>
</ref>
<ref id="B3">
<nlm-citation citation-type="">
<collab>Ministerio Salud Pública</collab>
<source><![CDATA[Informe Steps Ecuador]]></source>
<year>2018</year>
</nlm-citation>
</ref>
<ref id="B4">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Cuevas]]></surname>
<given-names><![CDATA[M. A]]></given-names>
</name>
<name>
<surname><![CDATA[Alonso K]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[DISLIPIDEMIA DIABÉTICA]]></article-title>
<source><![CDATA[Revista Médica Clínica Las Condes]]></source>
<year>2016</year>
<volume>27</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>152-9</page-range></nlm-citation>
</ref>
<ref id="B5">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Delgado Martin]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Mula]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Guilabert]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Solís]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Gómez]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Ramirez Amat]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Development and validation in Ecuador of the EPD Questionnaire, a diabetes-specific patient-reported experience and outcome measure: A mixed-methods study]]></article-title>
<source><![CDATA[Health Expectations]]></source>
<year>2021</year>
<volume>3</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>46-109</page-range></nlm-citation>
</ref>
<ref id="B6">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Pokharel]]></surname>
<given-names><![CDATA[DR]]></given-names>
</name>
<name>
<surname><![CDATA[Khadka]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Sigdel]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Yadav]]></surname>
<given-names><![CDATA[NK]]></given-names>
</name>
<name>
<surname><![CDATA[Acharya]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Kafle]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Prevalence and pattern of dyslipidemia in Nepalese individuals with type 2 diabetes]]></article-title>
<source><![CDATA[BMC Research Notes]]></source>
<year>2017</year>
<volume>10</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>146</page-range></nlm-citation>
</ref>
<ref id="B7">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Schofield]]></surname>
<given-names><![CDATA[JD]]></given-names>
</name>
<name>
<surname><![CDATA[Liu]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Rao-Balakrishna]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Malik]]></surname>
<given-names><![CDATA[RA]]></given-names>
</name>
<name>
<surname><![CDATA[Soran]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Diabetes Dyslipidemia]]></article-title>
<source><![CDATA[Diabetes Ther]]></source>
<year>2016</year>
<volume>7</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>203-19</page-range></nlm-citation>
</ref>
<ref id="B8">
<nlm-citation citation-type="">
<collab>OMS</collab>
<source><![CDATA[10 datos sobre la obesidad]]></source>
<year></year>
</nlm-citation>
</ref>
<ref id="B9">
<nlm-citation citation-type="">
<collab>WMA</collab>
<source><![CDATA[The World Medical Association-Declaración de la AMM sobre las Consideraciones Eticas de las Bases de Datos de Salud y los Biobancos]]></source>
<year>2020</year>
</nlm-citation>
</ref>
<ref id="B10">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Cordero]]></surname>
<given-names><![CDATA[SP]]></given-names>
</name>
<name>
<surname><![CDATA[M]]></surname>
<given-names><![CDATA[CT]]></given-names>
</name>
<name>
<surname><![CDATA[P]]></surname>
<given-names><![CDATA[CA]]></given-names>
</name>
<name>
<surname><![CDATA[Izquierdo]]></surname>
<given-names><![CDATA[PV]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Prevalencia y factores asociados a la dislipidemia en los adultos de las parroquias urbanas de la ciudad de Cuenca, 2015-2016]]></article-title>
<source><![CDATA[Archivos Venezolanos de Farmacología y Terapéutica]]></source>
<year>2017</year>
<volume>36</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>101-5</page-range></nlm-citation>
</ref>
<ref id="B11">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Cordero]]></surname>
<given-names><![CDATA[LCA]]></given-names>
</name>
<name>
<surname><![CDATA[C]]></surname>
<given-names><![CDATA[MAV]]></given-names>
</name>
<name>
<surname><![CDATA[Cordero]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Álvarez]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Añez]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Rojas]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Prevalencia de la diabetes mellitus tipo 2 y sus factores de riesgo en individuos adultos de la ciudad de Cuenca- Ecuador]]></article-title>
<source><![CDATA[Avances en Biomedicina]]></source>
<year>2017</year>
<volume>6</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>10-21</page-range></nlm-citation>
</ref>
<ref id="B12">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Parcero-Valdés]]></surname>
<given-names><![CDATA[JJ]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Dislipidemia diabética]]></article-title>
<source><![CDATA[Cardiovasc Metab Sci]]></source>
<year>2021</year>
<volume>32</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>168-72</page-range></nlm-citation>
</ref>
<ref id="B13">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Naqvi]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Naveed]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Ali]]></surname>
<given-names><![CDATA[Z]]></given-names>
</name>
<name>
<surname><![CDATA[Ahmad]]></surname>
<given-names><![CDATA[SM]]></given-names>
</name>
<name>
<surname><![CDATA[Khan]]></surname>
<given-names><![CDATA[RA]]></given-names>
</name>
<name>
<surname><![CDATA[Raj]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Correlation between Glycated Hemoglobin and Triglyceride Level in Type 2 Diabetes Mellitus]]></article-title>
<source><![CDATA[Cureus]]></source>
<year>2017</year>
<volume>9</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>1347-50</page-range></nlm-citation>
</ref>
<ref id="B14">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Martínez. M]]></surname>
<given-names><![CDATA[Rodríguez]]></given-names>
</name>
<name>
<surname><![CDATA[Otero. JA]]></surname>
<given-names><![CDATA[Soler]]></given-names>
</name>
<name>
<surname><![CDATA[Labrada. O]]></surname>
<given-names><![CDATA[Brizuela]]></given-names>
</name>
<name>
<surname><![CDATA[Sánchez. HN]]></surname>
<given-names><![CDATA[Santisteban]]></given-names>
</name>
<name>
<surname><![CDATA[Zamora. AL]]></surname>
<given-names><![CDATA[Berro]]></given-names>
</name>
<name>
<surname><![CDATA[Martínez. M]]></surname>
<given-names><![CDATA[Rodríguez]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Valor pronóstico de la hemoglobina glicada HbA1c en el padecimiento de retinopatía diabética en pacientes con diabetes mellitus tipo II]]></article-title>
<source><![CDATA[Multimed]]></source>
<year>2020</year>
<volume>24</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>399-415</page-range></nlm-citation>
</ref>
<ref id="B15">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Cruz Hernández]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Licea Puig]]></surname>
<given-names><![CDATA[ME]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Glucosilación no enzimática y complicaciones crónicas de la diabetes mellitus]]></article-title>
<source><![CDATA[Revista Cubana de Endocrinología]]></source>
<year>2010</year>
<volume>21</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>223-55</page-range></nlm-citation>
</ref>
<ref id="B16">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lira]]></surname>
<given-names><![CDATA[JCG]]></given-names>
</name>
<name>
<surname><![CDATA[Silva]]></surname>
<given-names><![CDATA[AP da]]></given-names>
</name>
<name>
<surname><![CDATA[Araújo]]></surname>
<given-names><![CDATA[MFM de]]></given-names>
</name>
<name>
<surname><![CDATA[Damasceno]]></surname>
<given-names><![CDATA[MMC]]></given-names>
</name>
<name>
<surname><![CDATA[Landim]]></surname>
<given-names><![CDATA[MBP]]></given-names>
</name>
<name>
<surname><![CDATA[Freitas]]></surname>
<given-names><![CDATA[RWJF de]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Controle metabólico e adesão medicamentosa em pessoas com diabetes mellitus]]></article-title>
<source><![CDATA[Acta paul enferm]]></source>
<year>2017</year>
<volume>30</volume>
<page-range>152-8</page-range></nlm-citation>
</ref>
<ref id="B17">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Landázuri]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Londoño-Franoo]]></surname>
<given-names><![CDATA[ÁL]]></given-names>
</name>
<name>
<surname><![CDATA[Restrepo-Cortés]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Bayona-Zorro]]></surname>
<given-names><![CDATA[AL]]></given-names>
</name>
<name>
<surname><![CDATA[Sánchez-López]]></surname>
<given-names><![CDATA[JF]]></given-names>
</name>
<name>
<surname><![CDATA[Landázuri]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Dislipidemia y relación con enfermedad tiroidea en agricultores de la zona cafetera]]></article-title>
<source><![CDATA[Acta Medica Colombiana]]></source>
<year>2019</year>
<volume>44</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>8-15</page-range></nlm-citation>
</ref>
<ref id="B18">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Rizos]]></surname>
<given-names><![CDATA[CV]]></given-names>
</name>
<name>
<surname><![CDATA[Elisaf]]></surname>
<given-names><![CDATA[MS]]></given-names>
</name>
<name>
<surname><![CDATA[Liberopoulos]]></surname>
<given-names><![CDATA[EN]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Effects of Thyroid Dysfunction on Lipid Profile]]></article-title>
<source><![CDATA[Open Cardiovasc Med J]]></source>
<year>2011</year>
<volume>5</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>76-84</page-range></nlm-citation>
</ref>
<ref id="B19">
<nlm-citation citation-type="journal">
<collab>Ghosh</collab>
<article-title xml:lang=""><![CDATA[Correlation of lipid profile among patients with hypothyroidism and type 2 diabetes mellitus]]></article-title>
<source><![CDATA[BLDE Univ J Health Sci]]></source>
<year>2018</year>
<volume>3</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>48-53</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
